Resilience Phenotypes and Psychological Functioning among Individuals with Opioid Use Disorder

被引:0
|
作者
Martinez, Suky [1 ,2 ]
Garcia-Romeu, Albert [3 ]
Perez, Freymon [1 ,2 ]
Jones, Jermaine D. [1 ,2 ]
机构
[1] Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, Div Subst Use Disorders, New York, NY 10027 USA
[2] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[3] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Behav Pharmacol Res Unit, Sch Med, Baltimore, MD USA
关键词
Resilience; opioid use disorder; heroin; five factor model of personality; heterogeneity; NEO-PI-R; DEPRESSION-INVENTORY-II; SUBSTANCE USE DISORDERS; PERSONALITY-TRAITS; TELOMERE LENGTH; MODERATING ROLE; DRUG-USE; ADDICTION; HEALTH; CONSCIENTIOUSNESS;
D O I
10.1080/10826084.2023.2259450
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Opioid use disorder (OUD) is a heterogeneous disorder. However, there is a lack of deep phenotyping investigations focusing on important psychological constructs such as resilience that may impact OUD. The present study aimed to investigate the relationship between trait resilience and the five-factor model of personality (FFM) among individuals with opioid use disorder (OUD). We also explored whether the FFM and trait resilience form specific phenotypes associated with psychological functioning. Methods: This secondary analysis of an epigenetic study included participants of African ancestry (n = 72), an understudied population, who met DSM-5 criteria for OUD. Participants completed measures to assess personality traits, trait resilience, current and previous drug use, and psychological functioning (depression, anxiety, and stress). Results: Linear regression revealed a significant relationship between resilience (CD-RISC-25 score) and the FFM, R-2 = 0.56, F(5,62) = 15.7, p<.001. Further, a two-cluster classification emerged as the optimal solution from the cluster analysis. Cluster 1 (n = 33, 45.8% of the sample) showed lower resilience (CD-RISC-25 score: M = 58.6, SD = 11.2) compared to Cluster 2 (n = 35, 48.6%; CD-RISC-25 score: M = 76.1, SD = 11.9). The "High-Resilience Cluster" (Cluster 2) was characterized by higher FFM traits of: Extraversion, Openness, Agreeableness, and Conscientiousness, and lower Neuroticism versus Cluster 1. Multivariate analysis of variance revealed statistically significant differences between the two resilience clusters concerning other psychological symptoms, ? = 0.732, F(4, 50) = 7.05, p < 0.003. Conclusions: These findings suggest associations between the FFM and trait resilience among individuals with OUD. Two distinct "resilience phenotypes" emerged, with high-resilience individuals displaying less stress, anxiety, and depressive symptoms. Results highlight the clinical importance of resilience as a potential target for intervention in people with OUD.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 50 条
  • [41] Brain Volume Alterations in Individuals With Opioid Use Disorder
    Mehta, Saloni
    Peterson, Hannah
    Ibrahim, Ahmad
    Saeed, Gul
    Linsky, Sarah
    Kreinin, Iouri
    Tsang, Sui
    Nwanaji-Enwerem, Uzoji
    Raso, Anthony
    Barry, Declan
    Redeker, Nancy S.
    Yaggi, Henry
    Scheinost, Dustin
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S235 - S235
  • [42] Multimodal Neuroimaging Findings in Individuals With Opioid Use Disorder
    Mehta, Saloni
    Peterson, Hannah
    Ibrahim, Ahmad
    Saeed, Gul
    Linsky, Sarah
    Kreinin, Iouri
    Tsang, Sui
    Nwanaji-Enwerem, Uzoji
    Raso, Anthony
    Arora, Jagriti
    Tokoglu, Fuyuze
    Hahn, C. Alice
    Lacadie, Cheryl
    Greene, Abigail S.
    Constable, Todd
    Barry, Declan
    Redeker, Nancy S.
    Yaggi, Henry
    Scheinost, Dustin
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S99 - S99
  • [43] RELATIONSHIP BETWEEN RESILIENCE AND ALCOHOL USE DISORDER AND ASSOCIATED PHENOTYPES
    Schwandt, M. L.
    Ramchandani, V. A.
    Kwako, L. E.
    Diazgranados, N.
    Goldman, D.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 : 251A - 251A
  • [44] Association between recent overdose and chronic pain among individuals in treatment for opioid use disorder
    Hartz, Sarah M.
    Culverhouse, Robert C.
    Mintz, Carrie M.
    Ellis, Matthew S.
    Kasper, Zachary A.
    Cavazos-Rehg, Patricia
    Grucza, Richard A.
    Bierut, Laura J.
    Cicero, Theodore J.
    PLOS ONE, 2022, 17 (11):
  • [45] The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder
    Friesen, Erik Loewen
    Kurdyak, Paul
    DRUG AND ALCOHOL DEPENDENCE, 2020, 216
  • [46] The association between addiction profile and early maladaptive schemas among individuals with opioid use disorder
    Demirbas, Rukiye
    Gokcay, Hasan
    Konkan, Ramazan
    JOURNAL OF SUBSTANCE USE, 2024,
  • [47] Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient Preference
    Lisa B. Puglisi
    Precious S. Bedell
    Anna Steiner
    Emily A. Wang
    Current Addiction Reports, 2019, 6 : 365 - 373
  • [48] A MIXED METHODS EXPLORATION OF STIGMA, DISCRIMINATION, AND SLEEP AMONG INDIVIDUALS ON MEDICATION FOR OPIOID USE DISORDER
    Nwanaji-Enwerem, Uzoji
    Sadler, Lois
    Jeon, Sangchoon
    Barry, Declan
    Yaggi, H.
    Redeker, Nancy
    SLEEP, 2023, 46 : A65 - A65
  • [49] Comorbid Health Conditions and Treatment Utilization among Individuals with Opioid Use Disorder Experiencing Homelessness
    Ali, Mir M.
    Sutherland, Harper
    Rosenoff, Emily
    SUBSTANCE USE & MISUSE, 2021, 56 (04) : 571 - 574
  • [50] Buprenorphine/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder
    Becker, William C.
    Ganoczy, Dara
    Fiellin, David A.
    Bohnert, Amy S. B.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 48 (01) : 128 - 131